RAS MUTATION

Clinical trials for RAS MUTATION explained in plain language.

Never miss a new study

Get alerted when new RAS MUTATION trials appear

Sign up with your email to follow new studies for RAS MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 1 Terminated 1

Experimental cancer drug DCC-3084 tested in early trial

Disease control Terminated

This early-phase trial tested an oral drug called DCC-3084, alone or with other cancer treatments, in 29 people with advanced solid tumors that have MAPK pathway mutations (like certain lung, pancreatic, or skin cancers). The study aimed to find safe doses and see if tumors shrin…

Matched conditions: RAS MUTATION

Phase: PHASE1 • Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Disease control

Last updated Jun 27, 2026 09:10 UTC

RAS MUTATION

Get alerted when new RAS MUTATION trials appear

Experimental cancer drug DCC-3084 tested in early trial